This inventor holds 89 USPTO granted patents and 19 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Liquid Crystal Technology (CPC class G01N21-77). Top assignees: Wisconsin Alumni Research Foundation, Platypus Technologies, LLC, University of California. Active years: 1998-2025.
Inventors with similar research interests:
Location History:
- Davis, CA (US) (1998 - 2005)
- Madison, WI (US) (2001 - 2023)
- Middleton, WI (US) (2023)
Company Filing History:
45 out of 4,234 
14 out of 16 
10 out of 15,977 
Years Active: 1998-2025
Areas of Expertise:
Title: Nicholas Lawrence Abbott: Innovator in Mucous Membrane Treatments
Introduction
Nicholas Lawrence Abbott, based in Madison, WI, is a prolific innovator with a remarkable portfolio of 83 patents. His work primarily focuses on advancements in medical treatments that involve altering mucous membranes, showcasing his commitment to improving healthcare solutions through innovative inventions.
Latest Patents
Abbott's latest patents illustrate his groundbreaking contributions to the field. One of his notable inventions is centered on "Methods and compositions for modifying mucous membranes," which involves techniques for treating diseases linked to these membranes by altering their intrinsic chemical composition and physical characteristics. Another significant patent is titled "Activated release of target material trapped in anisotropic fluids," where Abbott reveals systems and methods for the controlled release of guest compositions sequestered within anisotropic fluids. This invention addresses the challenge of releasing immiscible substances by manipulating elastic repulsion forces and introducing counter forces to achieve 'on-demand' delivery of chemical compositions.
Career Highlights
Throughout his career, Nicholas Abbott has made substantial contributions to research and development through his roles at esteemed organizations, including the Wisconsin Alumni Research Foundation and Platypus Technologies, LLC. His tenure at these institutions reflects his dedication to advancing scientific knowledge and practical applications within the medical field.
Collaborations
Abbott has collaborated with distinguished professionals in his field, including Christopher John Murphy and Barbara Israel. These partnerships have undoubtedly enhanced his ability to innovate and contribute to the advancement of medical technologies focusing on mucous membrane treatments.
Conclusion
Nicholas Lawrence Abbott's extensive array of patents, particularly in the area of mucous membranes, emphasizes his innovative spirit and dedication to improving health outcomes. His contributions continue to pave the way for new treatments and applications in medical science, cementing his status as a key figure in the world of invention and innovation.